Advertisement
Review| Volume 46, ISSUE 6, P729-739, September 15, 1999

Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective

  • Jeffrey A Lieberman
    Correspondence
    Address reprint requests to Jeffrey A. Lieberman, UNC School of Medicine, Dept. of Psychiatry, CB# 7160, 7025 Neurosciences Hospital, Chapel Hill, NC 27599
    Affiliations
    Mental Health and Neuroscience Clinical Research Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
    Search for articles by this author

      Abstract

      The history of psychiatric research is filled with widely accepted etiologic and pathophysiologic theories that eventually were proven wrong. The prevailing pathophysiologic theories of schizophrenia have emphasized the role of abnormal neurodevelopment in determining the onset and course of the illness. Relatively little attention has been paid to the role of neurodegenerative processes despite the clinical course of the illness and the fact that most patients experience varying degrees of behavioral and cognitive deterioration. This is partially due to the absence of clear histologic evidence of neurodegeneration, but may also be due to the narrow traditional conception of neurodegeneration that is generally employed. This article suggests that the rejection of a role for neurodegeneration in the pathophysiology of schizophrenia is unproven and may be premature. A wholly neurodevelopmental perspective of the illness imbues the illness with a pessimistic inevitability and therapeutic nihilism that may be unwarranted.
      This article reviews selectively a diverse body of evidence that is consistent with the hypothesis that schizophrenia involves a limited neurodegenerative process reflected by the psychotic symptoms and that is most active in the early stages of the illness. The evidence for this hypothesis comes from studies of premorbid status, illness course, symptomatology and treatment effects as well as neuroimaging and postmortem findings. Recent results from the latter interpreted in the context of molecular neurobiology suggest new pathophysiologic models.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Arnold S.E.
        • Trojanowski J.Q.
        • Gur R.E.
        • Blackwell P.
        • Han L.
        • Choi C.
        Absence of neurodegeneration and neural injury in the cerebral cortex in a sam ple of elderly patients with schizophrenia.
        Arch Gen Psychiatry. 1998; 55: 225-232
        • Baum K.M.
        • Walker E.F.
        Childhood behavioural precursors of adult symptom dimensions in schizophrenia.
        Schizophr Res. 1995; 16: 111-120
        • Benes F.M.
        Is there a neuroanatomic basis for schizophrenia? An old question revisited.
        The Neurosci. 1995; 1: 104-115
        • Bilder R.M.
        • Lipschutz-Broch
        • Reiter G.
        • Geisler S.H.
        • Mayerhoff D.I.
        • Lieberman J.A.
        Intellectual deficits in first-episode schizophrenia.
        Schizophr Bull. 1992; 18: 437-488
        • Bloom F.E.
        Advancing a neurodevelopmental origin for schizophrenia.
        Arch Gen Psychiatry. 1993; 50: 224-227
        • Bogerts B.
        Recent advances in the neuropathology of schizophrenia.
        Schizophr Bull. 1993; 19: 431-445
        • Bredesen D.E.
        Neural apoptosis.
        Ann Neurol. 1995; 38: 839-851
        • Buchsbaum M.S.
        • Haier R.J.
        • Potkin S.G.
        • Neuchterlein K.
        • Bracha H.S.
        • Katz M.
        • et al.
        Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics.
        Arch Gen Psychiatry. 1992; 49: 935-942
        • Buchsbaum M.S.
        • Potkin S.G.
        • Siegel Jr, B.V.
        • Lohr J.
        • Katz M.
        • Gottschalk L.A.
        • et al.
        Striatal metabolic rate and clinical response to neuroleptics in schizophrenia.
        Arch Gen Psychiatry. 1992; 49: 966-974
      1. Chatterjee and Lieberman (in press): Studies of first episode schizophrenia: A comprehensive review. In: McGorry P, Jackson H, editors: The Recognition and Management of Early Psychosis. Cambridge (UK): Cambridge University Press.

        • Cleghorn J.M.
        • Garnett E.S.
        • Nahmias C.
        • Firnau G.
        • Brown G.M.
        • Kaplan R.
        • et al.
        Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia.
        Psych Res. 1989; 28: 119-133
        • Coyle J.T.
        • Puttfarcken P.
        Oxidative stress, glutamate, and neurodegenerative disorders.
        Science. 1993; 262: 689-695
        • Davidson M.
        • Harvey P.D.
        • Powchik P.
        • Parella M.
        • White L.
        • Knobler H.Y.
        • et al.
        Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.
        Am J Psychiatry. 1995; 152: 197-207
        • Davis K.L.
        • Buchsbaum M.S.
        • Shihabuddin L.
        • Spiegel-Cohen J.
        • Metzger M.
        • Frecska E.
        • et al.
        Ventricular enlargement in poor-outcome schizophrenia.
        Biol Psychiatry. 1998; 43: 783-793
        • Davis J.M.
        • Andriukaitis S.
        The natural course of schizophrenia and effective maintenance drug treatment.
        J Clin Psychopharmacol. 1986; 6: 2S-10S
        • DeLisi L.E.
        • Twe W.
        • Xie S.-H.
        • Hoff A.L.
        • Sakuma M.
        • Kushner M.
        • et al.
        A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients.
        Biol Psychiatry. 1995; 38: 349-360
        • Done D.J.
        • Crow T.J.
        • Johnstone E.C.
        • Sacker A.
        Childhood antecedents of schizophrenia and affective illness.
        BMJ. 1994; 309: 699-703
        • Fenton W.S.
        • McGlashan T.H.
        Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia.
        Am J Psychiatry. 1994; 151: 351-356
      2. Franzen G, Ingvar DH (1975): Absence of activation in frontal structures during psychological testing of chronic schziophrenics. J of Neurol, Neurosurg and Psych 1027–1032.

        • Frazier J.A.
        • Giedd J.N.
        • Hamburger S.D.
        • Albus K.E.
        • Kaysen D.
        • Vaituzis A.C.
        • et al.
        Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia.
        Arch Gen Psychiatry. 1996; 53: 617-624
        • Goldberg T.E.
        • Gold J.M.
        Neurocognitive deficits in schizophrenia.
        in: Hirsch S.R. Weinberger D.R. Schizophrenia. Blackwell, Oxford1995: 146-162
        • Goldman-Rakic P.S.
        • Selemon L.D.
        Functional and anatomical aspects of prefrontal pathology in schizophrenia.
        Schiz Bull. 1997; 23: 437-458
        • Green M.
        • Satz P.
        • Christenson C.
        Minor physical abnormalities in schizophrenic patients, bipolar patients and their siblings.
        Schizophrenia Bull. 1994; 20: 433-449
        • Gur R.E.
        • Cowell P.
        • Turetsky B.I.
        • Gallacher N.
        • Cannon T.
        • Bilker W.
        • et al.
        A follow-up magnetic resonance imaging study of schizophrenia.
        Arch Gen Psychiatry. 1998; 55: 145-152
        • Hardy J.
        • Gwinn-Hardy K.
        Genetic classification of primary neurodegenerative disease.
        Science. 1998; 282: 1075-1079
        • Hare E.H.
        The changing content of psychiatric illness.
        J Psychosom Res. 1974; 18: 283-289
        • Haug O.J.
        Pneumoencephalographic studies in mental health.
        Acta Psychiatry Scand Suppl. 1962; 165: 1-114
        • Heaton R.
        • Paulsen J.S.
        • McAdams L.A.
        • Kuck J.
        • Zisook S.
        • Braff D.
        • et al.
        Neuropsychological deficits in schizophrenia.
        Arch Gen Psych. 1994; 51: 469-476
        • Hegarty J.D.
        • Baldessarini R.J.
        • Tohen M.
        • Waternaux C.
        • Oepen G.
        One hundred years of schizophrenia.
        Am J Psychiatry. 1994; 151: 1409-1416
        • Hoff A.L.
        • Riordan H.
        • O’Donnel D.W.
        • Morris L.
        • Delisi L.E.
        Neuropsychological functioning in first-episode schizophreniform patients.
        Am J Psychiatry. 1992; 149: 898-903
        • Horrobin D.F.
        • Geln A.I.M.
        • Vaddadi K.
        The membrane hypothesis of schizophrenia.
        Schizophr Res. 1994; 13: 195-207
        • Huber G.
        • Gross G.
        • Shuttler R.
        • Linz M.
        Longitudinal studies of schizophrenic patients.
        Schizophr Bull. 1980; 6: 592-605
        • Huber G.
        Pneumoencephalographische und psychopathologische Bilder beiendogen Psychosen. Springer International, Berlin1954
        • Illowsky B.P.
        • Juliano D.M.
        • Migelow L.B.
        • Weinberger D.R.
        Stability of CT scan findings in schizophrenia.
        J Neurol Neurosurg Psychiatry. 1988; 51: 209-213
        • Jacobi W.
        • Winkler H.
        Zur Frage der Spratschadigungen nach Encephalographie.
        Deutsche Ztschr. f. Nervenh. 1930; 112: 266-280
        • Jaskiw G.E.
        • Juliano D.M.
        • Goldberg T.E.
        • Hertzman M.
        • Urow-Harnell E.
        • Weinberger D.R.
        Cerebral ventricular enlargement in schizophreniform disorder does not progress. A seven year follow-up study.
        Schizopr Res. 1994; 14: 23-28
        • Johnstone E.C.
        Disabilities and circumstances of schizophrenic patients.
        Br J Psychiatry. 1991; 159: 5-46
        • Jones P.
        • Rodgers B.
        • Murray R.
        • Marmot M.
        Child development risk factors for adult schizophrenia in the British 1946 birth cohort.
        Lancet. 1994; 344: 1398-1402
        • Kemali D.
        • Maj M.
        • Galderisi S.
        • Milici N.
        • Salvati A.
        Ventricle-to-brain ratio in schizophrenia.
        Biol Psychiatry. 1989; 26: 756-759
        • Kendler K.S.
        • Diehl S.R.
        The genetics of schizophrenia.
        Schizophr Bull. 1993; 19: 261-285
        • Keshavan M.S.
        • Bagwell W.W.
        • Haas G.L.
        • Sweeney J.A.
        • Schooler N.
        • Pettegrew J.W.
        Changes in caudate volume with neuroleptic treatment.
        Lancet. 1994; 344 ([letter]): 1434
        • Kikinis R.
        • Shenton M.E.
        • Gerig G.
        • et al.
        Temporal lobe sulco-gyral pattern anomalies in schizophrenia.
        Neurosci Lett. 1994; 182: 7-12
        • Knoll 4th, J.L.
        • Garver D.L.
        • Ramberg J.E.
        • Kingsbury S.J.
        • Croissant D.
        • McDermott B.
        Heterogeneity of the psychoses.
        Schizophr Bull. 1998; 24: 365-379
        • Kraeplin E.
        Dementia Praecox and Paraphrenia. E&S Livingstone, Edinburgh, Scotland1919
        • Lewis D.A.
        Development of the prefrontal cortex during adolescence.
        Neuropsychopharmacology. 1997; 16: 358-398
        • Lieberman J.
        • Kane J.
        • Woerner M.
        • Alvir J.
        • Borenstein M.
        • Novacenko H.
        Prediction of relapse in schizophrenia.
        Clin Neuropharmacol. 1990; 13: 434-435
        • Lieberman J.A.
        • Bogerts B.
        • Degreef G.
        • Ashtari M.
        • Alvir J.
        Qualitative assessment of brain morphology in acute and chronic schizophrenia.
        Am J Psychiatry. 1992; 149: 784-794
        • Lieberman J.A.
        • Alvir J.M.
        • Koreen A.
        • Geisler S.
        • Chakos M.
        • Sheitman B.
        • Woerner M.
        Psychobiologic correlates of treatment response in schizophrenia.
        Neuropsychopharmacology. 1996; 14: 13S-21S
        • Lieberman J.A.
        • Sheitman B.B.
        • Kinon B.J.
        Neurochemical sensitization in the pathophysiology of schizophrenia.
        Neuropsychopharmacology. 1997; 17: 205-229
        • Lieberman J.A.
        • Sheitman B.
        • Chakos M.
        • Robinson D.
        • Schooler N.
        • Keith S.
        The development of treatment resistance in patients with schizophrenia.
        J Clin Psychopharmacol. 1998; 18: 20S-24S
        • Lim K.O.
        • Adalsteinsson E.
        • Spielman D.
        • et al.
        Proton MRS imaging of cortex in schizophrenia.
        Arch Gen Psychiatry. 1998; 55: 346-352
        • Loebel A.D.
        • Lieberman J.A.
        • Alvir J.M.J.
        • Mayerhoff D.I.
        • Geisler S.H.
        • Szymanski S.R.
        Duration of psychosis and outcome in first-episode schizophrenia.
        Am J Psychiatry. 1992; 149: 1183-1188
        • Lohr J.B.
        Oxygen radicals and neuropsychiatric illness.
        Arch Gen Psych. 1991; 48: 1097-1106
        • Margolis R.L.
        • Chuang D.M.
        • Post R.M.
        Programmed cell death.
        Biol Psychiatry. 1994; 35: 946-956
        • Mattson M.P.
        • Keller J.N.
        • Begley J.G.
        Evidence for synaptic apoptosis.
        Exper Neurology. 1998; 153: 34-48
        • McCreadie R.G.
        • Thara R.
        • Kamath S.
        • Padmavathy R.
        • Latha S.
        • Mathrubootham N.
        • et al.
        Abnormal movements in never-medicated Indian patients with schizophrenia.
        Br J Psychiatry. 1996; 168: 221-226
        • McGlashan T.H.
        A selective review of recent North American long-term follow-up studies of schizophrenia.
        Schiz Bull. 1988; 14: 515-542
        • McGlashan T.H.
        • Fenton W.S.
        Subtype progression and pathophysiologic deterioration in early schizophrenia.
        Schizophr Bull. 1993; 19: 71-84
        • Morrison J.R.
        Changes in subtype diagnosis of schizophrenia.
        Am J Psychiatry. 1974; 131: 674-677
        • Murray R.M.
        • Lewis S.W.
        Is schizophrenia a neurodevelopmental disorder?.
        BMJ. 1987; 296: 681-682
        • Nasrallah H.A.
        • Olson S.C.
        • McCalley-Whitters M.
        • Chapman S.
        • Jacoby C.G.
        Cerebral ventricular enlargement in schizophrenia.
        Arch Gen Psychiatry. 1986; 43: 157-159
        • Olney J.W.
        • Farber N.B.
        Glutamate receptor dysfunction and schizophrenia.
        Arch Gen Psychiatry. 1995; 52: 998-1007
        • Owens D.G.
        • Johnstone E.C.
        • Frith C.D.
        Spontaneous involuntary disorders of movement.
        Arch Gen Psychiatry. 1982; 39: 452-461
        • Pettegrew J.A.
        • Keshavan J.S.
        • Panchalingam K.
        • Strychor S.
        • Kaplan D.B.
        • Tretta M.G.
        • et al.
        Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naı̈ve schizophrenics.
        Arch Gen Psychiatry. 1991; 48: 563-568
        • Pfohl B.
        • Winokur G.
        The evolution of symptoms in institutionialized hebephrenic/catatonic schizophrenics.
        Br J Psychiatry. 1982; 141: 567-572
        • Purohit D.P.
        • Perl D.P.
        • Haroutunian V.
        • Powchik P.
        • Davidson M.
        • Davis K.L.
        Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia.
        Arch Gen Psychiatry. 1998; 55: 205-211
        • Rajkowska G.
        • Selemon L.D.
        • Goldman-Rakic P.S.
        Neuronal and glial somal size in the prefrontal cortex.
        Arch Gen Psychiatry. 1998; 55: 215-224
        • Rapoport J.L.
        • Giedd J.
        • Kumra S.
        • Jacobsen L.
        • Smith A.
        • Lee P.
        • et al.
        Childhood-onset schizophrenia.
        Arch Gen Psych. 1997; 54: 897-903
      3. Rapoport JL, Giedd JN, Blumental J, Hamburger S, Jeffries N, Fernandez T, et al (1999): Progressive cortical change during adolescence in childhood onset schizophrenia: A longitudinal MRI study. Arch Gen Psychiatry, in press.

        • Reddy R.
        • Yao J.K.
        Free radical pathology in schizophrenia.
        Prostaglandins Leukot Essent Fatty Acids. 1996; 55: 33-43
        • Roberts G.W.
        • Colter N.
        • Lofthouse R.
        • Johnstone E.C.
        • Crow T.J.
        Is there gliosis in schizophrenia? Investigation of the temporal lobe.
        Biol Psychiatry. 1987; 22: 1459-1468
        • Robinson D.
        • Woerner M.
        • Alvir J.
        • Bilder R.
        • Goldman R.
        • Geisler S.
        • et al.
        Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.
        Am J Psychiatry. 1999; 156: 544-549
        • Saykin A.J.
        • Shtase D.L.
        • Gur R.E.
        • Kester D.B.
        • Mozley L.H.
        • Stafiniak P.
        • et al.
        Neuropsychological deficits in neuroleptic-naı̈ve patients with first-episode schizophrenia.
        Arch Gen Psychiatry. 1994; 51: 124-131
      4. Shenton ME, Wible CG, McCarley RW. MRI studies in schizophrenia. In: Krishnan KRR, Doraiswamy PM, editors: Brain Imaging in Clinical Psychiatry. New York: Marcel Dekker, pp 297–380.

        • Szymanski S.R.
        • Cannon T.D.
        • Gallacher F.
        • Erwin R.J.
        • Gur R.E.
        Course of treatment response in first-episode and chronic schizophrenia.
        Am J Psychiatry. 1996; 153: 519-525
        • Southard E.E.
        On the topographical distribution of cortex lesions and anomalies in dementia praecox, with some account of their functional significance.
        Am J Insanity. 1915; 71: 603-671
        • Stanley J.A.
        • Williamson P.C.
        • Drost D.J.
        • Carr T.J.
        • Rylett R.J.
        • Malla A.
        • et al.
        An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy.
        Arch Gen Psychiatry. 1995; 52: 399-406
        • Stanley J.A.
        • Williamson P.C.
        • Drost D.J.
        • Rylett R.J.
        • Carr T.J.
        • Malla A.
        • et al.
        An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients.
        Schiz Bull. 1996; 22: 597-609
        • Szechtman H.
        • Nahmias C.
        • Garnett E.S.
        • Firnauy G.
        • Brown G.M.
        Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia.
        Arch Gen Psych. 1988; 45: 523-532
        • Vita A.
        • Sacchetti E.
        • Valvassori G.
        • Cazzullo C.L.
        Brain morphology in schizophrenia.
        Acta Psychiatr Scan. 1988; 78: 618-621
        • Vita A.
        • Dieci M.
        • Giobbio G.M.
        • Azzone P.
        • Garbarini M.
        • Sacchetti E.
        • et al.
        CT scan abnormalities and outcome of chronic schizophrenia.
        Am J Psychiatry. 1991; 148: 1577-1579
        • Waddington J.L.
        • Buckley P.F.
        The Neurodevelopmental Basis of Schizophrenia. Landes, Austin (TX)1996
        • Waddington J.L.
        • Scully P.J.
        • Youssef H.A.
        Developmental trajectory and disease progression in schizophrenia.
        Schiz Res. 1997; 23: 107-118
        • Waddington J.L.
        • Yuossef H.A.
        • Kinsella A.
        Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia.
        Psychol Med. 1995; 25: 849-857
        • Walker E.
        • Savoie T.
        • Davis D.
        Neuromotor precursors of schizophrenia.
        Schizophr Bull. 1994; 20: 441-451
        • Weinberger D.R.
        From neuropathology to neurodevelopment.
        Lancet. 1995; 346: 552-557
        • Weinberger D.R.
        Implications of normal brain development for the pathogenesis of schizophrenia.
        Arch Gen Psychiatry. 1987; 44: 660-669
        • Woods B.T.
        Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary Pathogenetic mechanism.
        Am J Psychiatry. 1998; 155: 1661-1670
        • Woods B.T.
        • Yurgelun-Todd D.
        • Benes F.M.
        • Frankenburg F.R.
        • Pope Jr, H.G.
        • McSparren J.
        Progressive ventricular enlargement in schizophrenia.
        Biol Psychiatry. 1990; 27: 341-352
        • Wyatt R.J.
        Neuroleptics and the natural course of schizophrenia.
        Schizophr Bull. 1991; 17: 325-351
        • Wyatt R.J.
        Early intervention for schizophrenia.
        Biol Psychiatry. 1995; 38: 1-3